Loading...
Correlation of HOXD3 promoter hypermethylation with clinical and pathologic features in screening prostate biopsies
BACKGROUND: Molecular markers that can discriminate indolent cancers from aggressive ones may improve the management of prostate cancer and minimize unnecessary treatment. Aberrant DNA methylation is a common epigenetic event in cancers and HOXD3 promoter hypermethylation (H3PH) has been found in pr...
Na minha lista:
Udgivet i: | Prostate |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , |
Format: | Artigo |
Sprog: | Inglês |
Udgivet: |
BlackWell Publishing Ltd
2014
|
Fag: | |
Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4285328/ https://ncbi.nlm.nih.gov/pubmed/24847526 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pros.22790 |
Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|